DRUG: Afelimomab Help Entry D07436                      Drug                                    Name Afelimomab (INN) Class Anti-inflammatory  DG01985  Disease modifying anti-rheumatic drug (DMARD)   DG01936  TNF inhibitor Remark ATC code:  L04AB03 Efficacy Immunosuppressant, Anti-TNF-alpha antibody   Type Monoclonal antibody Target TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]   Pathway hsa04010   MAPK signaling pathway hsa04060   Cytokine-cytokine receptor interaction hsa04210   Apoptosis hsa04350   TGF-beta signaling pathway hsa04612   Antigen processing and presentation hsa04920   Adipocytokine signaling pathway Interaction DDI search Brite Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS   L04 IMMUNOSUPPRESSANTS    L04A IMMUNOSUPPRESSANTS     L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors      L04AB03 Afelimomab       D07436  Afelimomab (INN) Drug groups [BR:br08330]  Anti-inflammatory   DG01985  Disease modifying anti-rheumatic drug (DMARD)    DG01936  TNF inhibitor     D07436  Afelimomab Target-based classification of drugs [BR:br08310]  Cytokines and receptors   Cytokines    Tumor necrosis factors     TNF (TNFA, TNFSF2)      D07436  Afelimomab (INN) BRITE hierarchy Other DBs CAS:  156227-98-4 PubChem:  51091768 LinkDB All DBs » Japanese version   » Back

DBGET integrated database retrieval system